Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dermira, Inc.
Menlo Park, California, United Statesdermira.com ↗
- Ownership
- Public · LLY
- Employees
- ~26
- Development stage
- Other
01
Overview
Dermira was a biopharmaceutical company focused on developing and commercializing innovative therapies for chronic skin conditions. Its pipeline included both late-stage clinical candidates and an FDA-approved product. The company was acquired by Eli Lilly & Co. in January 2020 to expand Lilly’s dermatology portfolio.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculesbiologics (focus on dermatology therapies)
- Industry
- Biotech
Beyond the preview
Go deeper on Dermira, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermira, Inc..